SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001829126-23-001912
Filing Date
2023-03-08
Accepted
2023-03-08 16:05:18
Documents
15
Period of Report
2023-03-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K organicellregen_8k.htm   iXBRL 8-K 46587
2 EXHIBIT 10.1 organicellregen_ex10-1.htm EX-10.1 168744
3 EXHIBIT 10.2 organicellregen_ex10-2.htm EX-10.2 159405
4 EXHIBIT 10.3 organicellregen_ex10-3.htm EX-10.3 80860
  Complete submission text file 0001829126-23-001912.txt   717881

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE ocel-20230306.xsd EX-101.SCH 3233
6 XBRL LABEL FILE ocel-20230306_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE ocel-20230306_pre.xml EX-101.PRE 22363
9 EXTRACTED XBRL INSTANCE DOCUMENT organicellregen_8k_htm.xml XML 3300
Mailing Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 300 MIAMI FL 33136 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

IRS No.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 000-55008 | Film No.: 23716131
SIC: 2836 Biological Products, (No Diagnostic Substances)